Allergan OPTIVE FUSION™
Allergan OPTIVE FUSION™ is a dual-polymer synergy uniquely formulated
to provide comfortable protection to maintain a
healthy tear film and relieve
aqueous-deficient dry eye.
The two most sought-after polymers in eye care can now be found in one
soothing single-drop formula.
Only OPTIVE FUSION™ combines the properties of
Carboxymethylcellulose (CMC) and
Hyaluronic Acid (HA) to lubricate, protect, and
restore a healthy tear film for instant relief of aqueous-deficient
dry eye.
OPTIVE FUSION™ is compatible with contact lenses and
can be used for up to three months before discarding.
Innovative technology
Twist off the end of the vial and hold upside
down, allowing each drop to fall into the eye
Avoid touching the surface of the eye or eyelids
with the applicator tip
Use one or two drops per eye as needed
Hyaluronic Acid (HA) based tears: 2,3
Soothes the symptoms of DED
Enhances water retention
Carboxymethylcellulose (CMC) Based Tears: 2-3
Stabilises the tear film by providing comfort and
lubrication
Improves ocular surface integrity
Long retention time
Osmoprotection Based Tears: 3,5
Helps protect the surface of your eyes by providing
hydration
Protects against hyperosmotic stress
Restores osmotic balance
Instillation
Place one or two drops of OPTIVE FUSION™ in the affected eye(s) as needed.
Step 1
Tilt your head back, look upwards, and gently pull down your lower eyelid to create a small gap.
Step 2
Hold the bottle upside down and allow each
drop to fall into the eye
Avoid touching the surface of the eye or eyelids
with the applicator tip
Use one or two drops per eye as needed
Step 3
Close the eye for two or three seconds to help spread OPTIVE PLUS™ UD evenly over the surface of the eye.
Ingredients
OPTIVE FUSION™ is supplied in plastic bottles containing 10ml
Each ml contains:
Sodium hyaluronate 0.1%
Sodium carboxymethylcellulose 0,5 %
Glycerine 0,9 %
PURITE® 0,01%
Precautions
- - Do not use if allergic to any of the ingredients
- - Do not swallow solution
- - To avoid contamination or possible eye injury, do not touch bottle tip on any surface, and avoid direct contact with the eye
- - Close the bottle tightly immediately after use
- - Discard any remaining solution 3 months after opening
- - Do not use after expiry date marked on the product
- - Keep out of the reach of children
- - Store at room temperature
- - Do not use the bottle if the tamper-proof seal on the bottle neck is broken before first use
- - Do not use if solution changes colour
- - Allow 5 minutes between the administrations of ophthalmic product
Add-on treatment
Higher-viscosity OPTIVE® GEL DROPS are an effective add-on treatment to OPTIVE PLUS™ , providing long-lasting relief both during the day and at night.
OPTIVE FUSION™ Eye Drops and
OPTIVE FUSION™ Unit Dose Eye Drops: Contains
sodium hyaluronate 1 mg/ml, carboxymethylcellulose sodium 5 mg/ml,
and glycerine 9 mg/ml.
OPTIVE® Gel Drops: Contains
carboxymethylcellulose sodium 10 mg/ml and glycerine 9 mg/ml.
For full prescribing information, refer to the
Instructions for Use.
Allergan Pharmaceuticals (Pty) Ltd, PO Box 6024, Halfway House,
1685, South Africa (Co. Reg. no. 1984/005576/07)
Telephone: +27 (0) 11 545 6600, Facsimile: +27 (0) 11 315 6008
www.allergan.co.za
© 2018. ®/™ Registered Trademark/Trademark of Allergan, Inc.
ZA/0104/2018
Clinical References
1. Allergan OPTIVE FUSION™ labelling, 2017. App: Section 5. 1. Jones L et al. Ocul Surf 2017, 15: 575-628
2. Simmons P et al. Clin Ophthalmol. 2015 ;15(9) : 665–675
3. TFOS DEWS II management and therapy report. The Ocular Surface. 2017;15(3): 575–628
4. Sanchez MA et al. Cornea. 2010;29(2): 167–171
5. Baudouin C et al. Ocul Surg. 2013;11: 246–248